Menu
Back to Journals » Drug Design, Development and Therapy » Volume 9
Review
Siltuximab (CNTO 328): a promising option for human malignancies
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 21,838 | Dovepress* | 18,428+ | 1,779 | 20,207 | |
| PubMed Central* | 3,410 | 544 | 3,954 | ||
| Totals | 21,838 | 2,323 | 24,161 | ||
|
*Since 2 July 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 3 | 0 | 0 | 0 | 1 | 2 |
View citations on PubMed Central and Google Scholar